Mindfulness-based cognitive therapy can prevent recurrent depression

702361266_359e089599_b

Sarah McDonald reports on a meta-analysis published yesterday, which found that when compared with active treatment, mindfulness-based cognitive therapy resulted in a reduced risk of depressive relapse.

[read the full story...]

Mindfulness-based cognitive therapy cannot substitute maintenance antidepressants for preventing depression relapse

7080859329_6e94729052_k

Ioana Cristea takes a closer look at a recent non-inferiority RCT, which compares mindfulness-based cognitive therapy (MBCT) plus discontinued antidepressants versus MBCT and maintenance antidepressants.

[read the full story...]

Is the NICE guideline for bipolar disorder biased in favour of psychosocial interventions?

3188732826_d2631dacc9_b

Guy Goodwin reviews a new paper in the Lancet Psychiatry by Jauhar, McKenna and Laws, that calls into question the trustworthiness of the NICE bipolar disorder guidance.

[read the full story...]

Can psychotherapy reduce the risk of relapse or recurrence of depression?

shutterstock_237206620

Sarah McDonald appraises a new systematic review that asks if psychological interventions can prevent relapse in adults who have recovered from depression.

[read the full story...]

Psychotherapy can reduce the risk of relapse or recurrence of depression

shutterstock_114034636

Raluca Lucacel summarises a meta-analysis of psychological interventions in preventing recurrence of depression, which includes trials on cognitive behavioural therapy, interpersonal therapy and mindfulness-based cognitive therapy.

[read the full story...]

Mindfulness-based cognitive therapy to prevent depression

In April 2015 we blogged PREVENT and concluded that mindfulness based cognitive therapy is a promising intervention for preventing depression.

André Tomlin presents the results of the PREVENT RCT published today in The Lancet, which investigates the effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence.

[read the full story...]

Eating disorders: mapping the (lack of) evidence

shutterstock_80397523

Helen Bould summarises a recent review that maps the evidence for the prevention and treatment of eating disorders in young people. Her conclusion? A call to arms for more better quality research to help people affected by these serious illnesses.

[read the full story...]

Targeted mindfulness-based relapse prevention may support long-term outcomes for substance use disorders

shutterstock_141036142

Approximately 10.6% of individuals with Substance Use Disorders (SUD) in the US seek treatment, with 40-60% relapsing within a year (Dept of Health and Human Services, 2008; McLellan et al, 2000). This highlights a real need for substance abuse treatment that focuses on relapse prevention. This blog summarises a recent RCT from JAMA Psychiatry on [read the full story…]

Extended therapy with varenicline reduces rates of smoking relapse in people with serious mental health issues

Woman with pill

People with serious mental health issues such as schizophrenia have higher rates of cigarette smoking than the general population, with estimates suggesting more than 50% are current smokers. When people in this population do manage to quit during treatment we then see particularly high rates of relapse after treatment ends. A new randomised control trial (Evins [read the full story…]

Quitting smoking is the easy part, staying quit is hard

shutterstock_99385985

During 2010/11 there were 1.53 million hospital admissions for illnesses directly attributable to smoking in the UK. These admissions, along with other smoking-related expenses, cost the NHS approximately £5 billion pounds per year. Fortunately, the NHS is spending £88.2 million per year on cessation treatments, many of which have been repeatedly demonstrated to be highly [read the full story…]